Clinical trial
Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
NCT00451984 · Aalborg University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00451984 |
|---|---|
| Title | Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 |
| Acronym | HEPVACHIV |
| Lead sponsor | Aalborg University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Hepatitis A, Hepatitis B |
| Intervention type | Biological |
| Interventions | Twinrix, interleukin-2 |
| Enrollment | 80 |
| Start date | Mar 1, 2007 |
| First posted | Mar 26, 2007 |
| Last update posted | Nov 1, 2007 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: